{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:17:26Z","timestamp":1789049846974,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.phrs.2022.106506","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T04:40:37Z","timestamp":1665549637000},"page":"106506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The specific deletion of cyclooxygenase-1 in megakaryocytes\/platelets reduces intestinal polyposis in Apc mice"],"prefix":"10.1016","volume":"185","author":[{"given":"Annalisa","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Contursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Hofling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Lamolinara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106506_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.phrs.2022.106506_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2022.106506_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani P","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2022.106506_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2022.106506_bib5","first-page":"4705","article-title":"Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice","volume":"60","author":"Chulada","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2022.106506_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2022.106506_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2022.106506_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0000000000000003","article-title":"An inflammatory mediator, prostaglandin E2, in colorectal cancer","volume":"19","author":"Wang","year":"2013","journal-title":"Cancer J."},{"key":"10.1016\/j.phrs.2022.106506_bib10","doi-asserted-by":"crossref","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2022.106506_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"1851","author":"Patrignani P","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2022.106506_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-3-642-30331-9_2","article-title":"Mechanistic aspects of COX-2 expression in colorectal neoplasia","volume":"191","author":"Dixon","year":"2013","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0959-8049(95)00181-H","article-title":"ApcMin: a mouse model for intestinal and mammary tumorigenesis","volume":"31A","author":"Moser","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phrs.2022.106506_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1350108","article-title":"Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene","volume":"256","author":"Su","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2022.106506_bib15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2011-300817","article-title":"\u03b2-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells","volume":"61","author":"Smartt","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2022.106506_bib16","first-page":"4872","article-title":"Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis","volume":"63","author":"Takeda","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.119.259382","article-title":"Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice","volume":"370","author":"Sacco","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2022.106506_bib18","doi-asserted-by":"crossref","first-page":"14823","DOI":"10.1038\/s41598-018-33167-7","article-title":"Laboratory diagnostics of murine blood for detection of mouse cytomegalovirus (MCMV)-induced hepatitis","volume":"8","author":"Stahl","year":"2018","journal-title":"Sci., Rep."},{"key":"10.1016\/j.phrs.2022.106506_bib19","first-page":"80","article-title":"More than two decades of Apc modeling in rodents","volume":"1836","author":"Zeineldin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2022.106506_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105744","article-title":"Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A2 is unrestrained","volume":"170","author":"D'Agostino","year":"2021","journal-title":"Pharmacol. Res"},{"key":"10.1016\/j.phrs.2022.106506_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.113.084988","article-title":"Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells","volume":"84","author":"Dovizio","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106506_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCRESAHA.108.191114","article-title":"Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells","volume":"104","author":"Di Francesco","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2022.106506_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0016-5085(98)70305-1","article-title":"Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin","volume":"114","author":"Barnes","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106506_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(87)80865-7","article-title":"Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division","volume":"220","author":"Celis","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2022.106506_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb. Res."},{"key":"10.1016\/j.phrs.2022.106506_bib26","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/01.CIR.0000124715.27937.78","article-title":"Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects","volume":"109","author":"Capone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106506_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1940-6207.CAPR-13-0153","article-title":"Urinary PGE-M: a promising cancer biomarker","volume":"6","author":"Wang","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.phrs.2022.106506_bib28","doi-asserted-by":"crossref","first-page":"132ra54","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2022.106506_bib29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","article-title":"Niacin and biosynthesis of PGD\u2082 by platelet COX-1 in mice and humans","volume":"122","author":"Song","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106506_bib30","first-page":"6846","article-title":"Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps","volume":"62","author":"Sonoshita","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib31","doi-asserted-by":"crossref","first-page":"31720","DOI":"10.1074\/jbc.M104036200","article-title":"Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts","volume":"276","author":"Faour","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106506_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106506_bib33","doi-asserted-by":"crossref","first-page":"37839","DOI":"10.1074\/jbc.M010606200","article-title":"Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2","volume":"276","author":"Caughey","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106506_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cpt.639","article-title":"Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer","volume":"102","author":"Patrignani","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2022.106506_bib35","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1101\/gad.351605","article-title":"Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis","volume":"19","author":"Ruvinsky","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2022.106506_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phrs.2022.106506_bib37","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","article-title":"Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis","volume":"68","author":"Nakanishi","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/ar1748","article-title":"Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2","volume":"7","author":"Sampey","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106506_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(00)01367-3","article-title":"Human glutathione dependent prostaglandin E synthase: gene structure and regulation","volume":"471","author":"Forsberg","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2022.106506_bib40","first-page":"153","article-title":"The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer","volume":"1805","author":"Cathcart","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2022.106506_bib41","first-page":"734","article-title":"Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer","volume":"62","author":"Keith","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2022.106506_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.7015512","article-title":"Prostacyclin: a potent antimetastatic agent","volume":"212","author":"Honn","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.phrs.2022.106506_bib43","first-page":"518","article-title":"Altered eicosanoid levels in human colon cancer","volume":"122","author":"Rigas","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.phrs.2022.106506_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","article-title":"International CAPP consortium. A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis","volume":"4","author":"Burn","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.phrs.2022.106506_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2468-1253(21)00018-2","article-title":"Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomized, two-by-two factorial design trial","volume":"6","author":"Ishikawa","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2022.106506_bib46","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jth.12637","article-title":"Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action","volume":"12","author":"Patrignani","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2022.106506_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114094","article-title":"Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems","volume":"178","author":"Tacconelli","year":"2020","journal-title":"Biochem. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822004522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822004522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:40:59Z","timestamp":1760913659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"alternative-id":["S1043661822004522"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106506","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The specific deletion of cyclooxygenase-1 in megakaryocytes\/platelets reduces intestinal polyposis in ApcMin\/+ mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106506"}}